11 stories
Milky Mist Dairy Food's IPO was subscribed 70% on Day 1, led by retail investors. The grey market premium (GMP) indicates a potential 15%…
Molbio Diagnostics IPO entered Day 2 with a GMP of Rs 127, indicating a potential 15.7% listing gain. Here's the subscription status…
Dhoot Transmission IPO entered Day 2 with a GMP of Rs 250, indicating a potential 29% listing gain. Here's everything investors should know…
Shadowfax Technologies shares are set to list on BSE and NSE today. Grey market trends hint at a slightly weak debut.
Bharat Coking Coal IPO Day 2 sees strong demand and steady GMP. Check subscription status, key risks and whether you should invest.
Meesho debuts at a 46% premium, listing at ₹162 after its IPO was subscribed 81.76 times. Investors weigh profit booking vs long-term…
Aequs lists at ₹140, a 13% premium over issue price. IPO saw 104x subscription. Experts suggest booking partial profits and holding long…
Corona Remedies IPO nears 10x subscription on Day 3; GMP at ₹265 hints at 25% listing gains as brokerages recommend long-term subscribe.
Aequs IPO subscribed 5.43x with strong retail demand; GMP at ₹45.5 hints at 36.69% listing gains. Analysts recommend long-term investment.
Canara Robeco IPO Day 2 updates: GMP ₹35, retail 0.74x subscribed. Long-term investors may consider applying despite OFS structure.
The stories that matter, in your inbox by 8 AM. Free, no spam.
